Skip to content
HowShorted

Accendra Health, Inc. short interest in 2025

In 2025, Accendra Health, Inc.'s disclosed short interest ran from 5.77% of shares outstanding on 15 Jan 2025 to 11.66% on 31 Dec 2025, a change of +5.89 percentage points. The year's high was 13.00% on 15 Dec 2025 and its low 4.57% on 31 Mar 2025, averaging 9.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.09 days on 31 Jan 2025. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2025

2025 in figures

Start of year
5.77% (15 Jan 2025)
End of year
11.66% (31 Dec 2025)
Change
+5.89 pp
High
13.00% (15 Dec 2025)
Low
4.57% (31 Mar 2025)
Average
9.25%
Highest days to cover
12.09 (31 Jan 2025)
SEC filings marked
9

Every report in 2025

Accendra Health, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20255.77%6.75
31 Jan 20255.98%12.09
14 Feb 20256.10%2.19results (8-K)
28 Feb 20256.25%1.3810-K filed, results (8-K)
14 Mar 20254.77%1.99
31 Mar 20254.57%2.67
15 Apr 20257.10%2.74
30 Apr 20259.18%5.74
15 May 20259.33%5.7310-Q filed, results (8-K)
30 May 20259.39%5.67
13 Jun 202511.01%6.22
30 Jun 20259.28%4.16
15 Jul 20258.26%6.16
31 Jul 20259.02%8.36
15 Aug 20259.57%2.9010-Q filed, results (8-K)
29 Aug 202511.91%5.98
15 Sep 202512.87%4.68
30 Sep 202510.09%2.20
15 Oct 202510.89%4.45
31 Oct 202510.45%4.36results (8-K), 10-Q filed
14 Nov 202512.57%4.09
28 Nov 202512.98%5.86
15 Dec 202513.00%5.04
31 Dec 202511.66%4.84

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.